Income Statement Evotec SE CBOE

Stocks

0IRF

DE0005664809

Biotechnology & Medical Research

Market Closed - CBOE 18:30:00 11/09/2026 +03			5-day change	1st Jan Change
3.217 ^EUR	0.00%		0.00%	-40.37%

09-09	Evotec Initiates Phase 1 Trial of Potential Smallpox, Mpox Treatment	MT
09-09	Evotec Commences Early-stage Study of Potential Orthopoxvirus Therapy	MT

2cb5ced81b93d75f78cd10.9cOT5FBkHwnZRcYp122dOo91xI2OiPJBsoRh-CDr-q4.oaf4kR1RdkTpKf4dpwewecc0l-rg_oV4wsYFyVS9ucDNs_qdfRdqZIoqnw

Published financial data: EVOTEC SE

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Revenues	618M	751M	781M	797M	788M
Total Revenues	618M	751M	781M	797M	788M
Cost of Goods Sold, Total	466M	577M	606M	682M	674M
Gross Profit	152M	174M	175M	115M	114M
Selling General & Admin Expenses, Total	105M	156M	170M	188M	176M
R&D Expenses	72.2M	76.64M	68.53M	50.86M	37.51M
Other Operating Expenses	-65.33M	-79.1M	-64.09M	-45.26M	-33.23M
Other Operating Expenses, Total	112M	154M	174M	194M	180M
Operating Income	39.23M	20.33M	1M	-78.92M	-66.03M
Interest Expense, Total	-9.25M	-13.15M	-11.74M	-11.7M	-
Interest And Investment Income	2.3M	8.34M	9.26M	2.44M	4.42M
Net Interest Expenses	-6.96M	-4.81M	-2.48M	-9.26M	4.42M
Income (Loss) On Equity Invest.	-16.57M	-15.96M	-20.75M	-4.31M	-1.08M
Currency Exchange Gains (Loss)	7.84M	13.08M	-2.5M	4.4M	17.6M
Other Non Operating Income (Expenses)	-61K	-727K	1.79M	-3.76M	-51.49M
EBT, Excl. Unusual Items	23.48M	11.91M	-22.94M	-91.86M	-96.58M
Restructuring Charges	-	-	-	-54.93M	-633K
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	212M	-171M	-9.14M	-38.51M	12.12M
Gain (Loss) On Sale Of Assets	-147K	-178K	-	-	-
Asset Writedown	-683K	-	-5.01M	-	-
Other Unusual Items	2.6M	5.61M	-43.5M	-8.67M	-1.68M
EBT, Incl. Unusual Items	237M	-154M	-80.59M	-194M	-86.77M
Income Tax Expense	21.47M	21.7M	3.32M	2.1M	16.75M
Earnings From Continuing Operations	216M	-176M	-83.91M	-196M	-104M
Net Income to Company	216M	-176M	-83.91M	-196M	-104M
Minority Interest	-	-	-	-	-
Net Income - (IS)	216M	-176M	-83.91M	-196M	-104M
Net Income to Common Incl Extra Items	216M	-176M	-83.91M	-196M	-104M
Net Income to Common Excl. Extra Items	216M	-176M	-83.91M	-196M	-104M
Per Share Items
Net EPS - Basic	1.3	-0.99	-0.47	-1.11	-0.58
Basic EPS - Continuing Operations	1.3	-0.99	-0.47	-1.11	-0.58
Basic Weighted Average Shares Outstanding	166M	177M	177M	177M	178M
Net EPS - Diluted	1.3	-0.99	-0.47	-1.11	-0.58
Diluted EPS - Continuing Operations	1.3	-0.99	-0.47	-1.11	-0.58
Diluted Weighted Average Shares Outstanding	167M	177M	177M	177M	178M
Normalized Basic EPS	0.09	0.04	-0.08	-0.32	-0.34
Normalized Diluted EPS	0.09	0.04	-0.08	-0.32	-0.34
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	89.32M	81.77M	72.08M	651K	8.74M
EBITA	49.56M	27.75M	7.13M	-72.95M	-61.57M
EBIT	39.23M	20.33M	1M	-78.92M	-66.03M
EBITDAR	90.22M	82.3M	72.38M	991K	9.92M
Effective Tax Rate - (Ratio)	9.06	-14.09	-4.12	-1.08	-19.31
Total Current Taxes	16.4M	13.98M	7.92M	7.43M	2.06M
Total Deferred Taxes	5.07M	7.72M	-4.6M	-5.33M	14.69M
Normalized Net Income	14.68M	7.44M	-14.34M	-57.41M	-60.36M
Interest Capitalized	-	-	-	2.62M	1.64M
Interest on Long-Term Debt	3.73M	3.84M	5.83M	4.73M	4.62M
Non-Cash Pension Expense	98K	110K	-402K	-1.39M	383K
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	73.52M	77.73M	73.9M	50.45M	37.92M
Net Rental Expense, Total	895K	526K	298K	340K	1.18M
Imputed Operating Lease Interest Expense	132K	109K	49.41K	73.12K	34.8K
Imputed Operating Lease Depreciation	763K	417K	249K	267K	1.14M
Stock-Based Comp., Other (Total)	7.8M	9.92M	9.63M	5.04M	3.78M
Total Stock-Based Compensation	7.8M	9.92M	9.63M	5.04M	3.78M

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Assets
Cash And Equivalents	699M	415M	511M	306M	419M
Short Term Investments	159M	303M	93.2M	90.41M	57.87M
Total Cash And Short Term Investments	858M	718M	604M	397M	476M
Accounts Receivable, Total	153M	202M	123M	162M	164M
Other Receivables	23.42M	54.42M	80.66M	41.88M	38.45M
Total Receivables	177M	257M	204M	204M	203M
Inventory	25.79M	29.82M	30.89M	31.12M	29.32M
Prepaid Expenses	19.21M	16.95M	18.4M	22.24M	18.97M
Other Current Assets, Total	20.95M	51.67M	45.71M	27.57M	35.56M
Total Current Assets	1.1B	1.07B	903M	682M	763M
Gross Property Plant And Equipment	686M	921M	1.16B	1.3B	1.07B
Accumulated Depreciation	-201M	-271M	-350M	-478M	-520M
Net Property Plant And Equipment	485M	650M	807M	824M	555M
Long-term Investments	282M	147M	142M	42.15M	52.63M
Goodwill	258M	275M	276M	283M	272M
Other Intangibles, Total	30.85M	23.82M	15.45M	26.44M	31.57M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	17.36M	10.33M	14.33M	17.33M	2.95M
Other Long-Term Assets, Total	61.98M	77.32M	95.23M	37.82M	36.86M
Total Assets	2.24B	2.26B	2.25B	1.91B	1.71B
Liabilities
Accounts Payable, Total	72.6M	97.28M	134M	85.79M	64.76M
Accrued Expenses, Total	35.46M	49.22M	50.9M	46.35M	51.12M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	36.14M	1.56M	130M	27.11M	81.5M
Current Portion of Leases	14.47M	14.82M	19.12M	19.56M	22.18M
Current Income Taxes Payable	10.6M	8.99M	5.56M	8.52M	10.58M
Unearned Revenue Current, Total	127M	137M	108M	110M	108M
Other Current Liabilities	28.47M	29.17M	16.85M	47.44M	29.86M
Total Current Liabilities	325M	338M	465M	345M	368M
Long-Term Debt	326M	328M	308M	260M	195M
Long-Term Leases	136M	162M	169M	132M	149M
Unearned Revenue Non Current	34.48M	206M	155M	187M	154M
Pension & Other Post Retirement Benefits	12.95M	12.53M	11.99M	10.22M	10.31M
Deferred Tax Liability Non Current	17.69M	18.52M	18.14M	14.52M	14.74M
Other Non Current Liabilities	5.54M	4.87M	5.46M	10.67M	9.44M
Total Liabilities	857M	1.07B	1.13B	960M	900M
Common Stock, Total	177M	177M	177M	178M	178M
Additional Paid In Capital	1.43B	1.44B	1.45B	1.45B	1.46B
Retained Earnings	-216M	-392M	-476M	-672M	-776M
Treasury Stock	-	-	-	-	-1.55M
Comprehensive Income and Other	-12.64M	-37.4M	-30.64M	-7.35M	-45.11M
Total Common Equity	1.38B	1.19B	1.12B	953M	814M
Minority Interest	-	-	-	-	-
Total Equity	1.38B	1.19B	1.12B	953M	814M
Total Liabilities And Equity	2.24B	2.26B	2.25B	1.91B	1.71B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	176M	177M	177M	177M	178M
ECS Total Common Shares Outstanding	176M	177M	177M	177M	178M
Book Value / Share	7.81	6.72	6.33	5.37	4.58
Tangible Book Value	1.09B	889M	829M	643M	510M
Tangible Book Value Per Share	6.18	5.03	4.68	3.63	2.87
Total Debt	513M	507M	626M	439M	448M
Net Debt	-345M	-212M	22.09M	42.62M	-28.7M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	-	14.87M	12.24M	12.16M
Debt Equivalent Oper. Leases	7.16M	4.21M	2.38M	2.72M	9.43M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	-
Equity Method Investments, Total	13.07M	16.04M	3.07M	2.14M	4.63M
Account Code - Inventory Valuation	8	8	8	6	6
Inventories - Raw Materials, Total	25.04M	27.92M	25.9M	29.46M	26.98M
Inventories - Work In Process, Total	750K	1.91M	4.99M	1.67M	2.33M
Buildings, Total	201M	240M	274M	323M	314M
Machinery, Total	258M	335M	401M	498M	481M
Full Time Employees	4.2K	4.95K	5.06K	4.74K	4.47K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	2.1M	2.83M	-	-	-
Order Backlog	-	-	-	-	-

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Net Income	216M	-176M	-83.91M	-196M	-104M
Depreciation & Amortization - CF	55.6M	72.68M	86.03M	95.13M	90M
Amortization of Goodwill and Intangible Assets - (CF)	10.33M	7.42M	6.12M	5.97M	4.45M
Depreciation & Amortization, Total	65.93M	80.1M	92.16M	101M	94.45M
Amortization of Deferred Charges, Total - (CF)	1.68M	1.56M	822K	518K	5.02M
(Gain) Loss From Sale Of Asset	142K	178K	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-224M	172M	9.14M	48.19M	-8.38M
Asset Writedown & Restructuring Costs	683K	-	5.01M	12.2M	797K
(Income) Loss On Equity Investments - (CF)	28.43M	15.1M	20.75M	4.31M	1.08M
Stock-Based Compensation (CF)	7.8M	9.92M	9.63M	5.04M	3.78M
Other Operating Activities, Total	27.95M	-19.51M	-7.22M	111M	58.38M
Change In Accounts Receivable	-48.03M	-38.43M	-	-	-28.73M
Change In Inventories	-11.65M	-4.41M	-	-	-9.56M
Change In Accounts Payable	31.34M	24.55M	-	-	-7.3M
Change in Unearned Revenues	63.08M	182M	-	-	-
Change In Income Taxes	18.85M	29.39M	-	-	-
Change in Other Net Operating Assets	-55.87M	-73.58M	-9.94M	-68.21M	-15.21M
Cash from Operations	122M	203M	36.44M	18.22M	-9.18M
Capital Expenditure	-119M	-181M	-213M	-117M	-72.54M
Sale of Property, Plant, and Equipment	-	-	530K	2M	214K
Cash Acquisitions	-410K	-20.86M	2.09M	-	-
Sale (Purchase) of Intangible assets	-	-	-2.68M	-14.77M	-10.08M
Investment in Marketable and Equity Securities, Total	-117M	-209M	190M	49.06M	249M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-7.38M	-4.13M	-	-	-
Other Investing Activities, Total	-	-	10.36M	9.99M	5.17M
Cash from Investing	-244M	-416M	-13.29M	-71.19M	172M
Long-Term Debt Issued, Total	30.79M	-	220M	900K	43.96M
Total Debt Issued	30.79M	-	220M	900K	43.96M
Long-Term Debt Repaid, Total	-36.68M	-53.11M	-135M	-153M	-73.38M
Total Debt Repaid	-36.68M	-53.11M	-135M	-153M	-73.38M
Issuance of Common Stock	404M	699K	219K	368K	225K
Repurchase of Common Stock	-	-	-	-	-1.55M
Other Financing Activities, Total	-	-	-12.85M	-9.72M	-6.89M
Cash from Financing	398M	-52.41M	71.96M	-161M	-37.63M
Foreign Exchange Rate Adjustments	-66K	-19.04M	644K	9.87M	-12.65M
Miscellaneous Cash Flow Adjustments	-	-	-1K	-	-
Net Change in Cash	277M	-284M	95.75M	-205M	112M
Supplemental Items
Cash Interest Paid	5.43M	9.8M	12.85M	5.92M	5.42M
Cash Income Tax Paid (Refund)	-6.03M	18.5M	12.9M	-76.08M	-14.78M
Levered Free Cash Flow	4.87M	-150M	-69.8M	-85.91M	-55.54M
Unlevered Free Cash Flow	10.65M	-142M	-62.47M	-78.6M	-55.54M
Change In Net Working Capital	-29.66M	65.06M	-50.29M	3.69M	34.91M
Net Debt Issued / Repaid	-5.89M	-53.11M	84.6M	-152M	-29.42M

Fiscal Period: December	2021 (EUR)	2022 (EUR)	2023 (EUR)	2024 (EUR)	2025 (EUR)
Profitability
Return on Assets	1.33	0.57	0.03	-2.37	-2.28
Return on Total Capital	1.58	0.71	0.04	-3.14	-3.11
Return On Equity %	20.5	-13.7	-7.27	-18.92	-11.72
Return on Common Equity	20.5	-13.7	-7.27	-18.92	-11.72
Margin Analysis
Gross Profit Margin %	24.52	23.16	22.4	14.41	14.49
SG&A Margin	17.06	20.79	21.71	23.61	22.32
EBITDA Margin %	14.45	10.88	9.22	0.08	1.11
EBITA Margin %	8.02	3.69	0.91	-9.15	-7.81
EBIT Margin %	6.35	2.71	0.13	-9.9	-8.38
Income From Continuing Operations Margin %	34.87	-23.38	-10.74	-24.6	-13.13
Net Income Margin %	34.87	-23.38	-10.74	-24.6	-13.13
Net Avail. For Common Margin %	34.87	-23.38	-10.74	-24.6	-13.13
Normalized Net Income Margin	2.37	0.99	-1.83	-7.2	-7.66
Levered Free Cash Flow Margin	0.79	-20.01	-8.93	-10.78	-7.05
Unlevered Free Cash Flow Margin	1.72	-18.91	-7.99	-9.86	-7.05
Asset Turnover
Asset Turnover	0.33	0.33	0.35	0.38	0.43
Fixed Assets Turnover	1.5	1.32	1.07	0.98	1.14
Receivables Turnover (Average Receivables)	4.87	4.23	4.8	5.58	4.83
Inventory Turnover (Average Inventory)	23.69	20.76	19.97	22	22.31
Short Term Liquidity
Current Ratio	3.39	3.18	1.94	1.98	2.07
Quick Ratio	3.19	2.89	1.74	1.74	1.85
Operating Cash Flow to Current Liabilities	0.38	0.6	0.08	0.05	-0.02
Days Sales Outstanding (Average Receivables)	74.96	86.37	76.07	65.61	75.61
Days Outstanding Inventory (Average Inventory)	15.41	17.58	18.27	16.64	16.36
Average Days Payable Outstanding	43.9	53.32	69.58	59.03	40.87
Cash Conversion Cycle (Average Days)	46.46	50.63	24.76	23.22	51.1
Long Term Solvency
Total Debt/Equity	37.23	42.68	55.92	46.13	55.02
Total Debt / Total Capital	27.13	29.91	35.86	31.57	35.49
LT Debt/Equity	33.56	41.3	42.6	41.23	42.28
Long-Term Debt / Total Capital	24.45	28.95	27.32	28.22	27.27
Total Liabilities / Total Assets	38.36	47.41	50.28	50.19	52.52
EBIT / Interest Expense	4.24	1.55	0.09	-6.75	-
EBITDA / Interest Expense	11.36	7.64	7.94	1.9	-
(EBITDA - Capex) / Interest Expense	-1.49	-6.15	-10.24	-8.14	-
Total Debt / EBITDA	4.88	5.05	6.72	19.81	15.75
Net Debt / EBITDA	-3.28	-2.11	0.24	1.92	-1.01
Total Debt / (EBITDA - Capex)	-37.2	-6.26	-5.21	-4.61	-10.15
Net Debt / (EBITDA - Capex)	25.04	2.62	-0.18	-0.45	0.65
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	23.38	21.59	3.99	1.99	-1.08
Gross Profit, 1 Yr. Growth %	20.52	14.86	0.57	-34.37	-0.57
EBITDA, 1 Yr. Growth %	0.53	-8.46	-14.01	-99.1	1.24K
EBITA, 1 Yr. Growth %	-21.05	-44	-75.71	-1.12K	-15.6
EBIT, 1 Yr. Growth %	-22.55	-48.18	-95.19	-7.97K	-16.33
Earnings From Cont. Operations, 1 Yr. Growth %	3.33K	-181.51	-52.23	133.67	-47.21
Net Income, 1 Yr. Growth %	3.33K	-181.51	-52.23	133.67	-47.21
Normalized Net Income, 1 Yr. Growth %	-11.3	-49.29	-272.55	300.45	-25.92
Diluted EPS Before Extra, 1 Yr. Growth %	3.14K	-176.77	-52.29	134.03	-47.48
Accounts Receivable, 1 Yr. Growth %	52.57	31.94	-39.01	31.57	1.17
Inventory, 1 Yr. Growth %	89.86	15.63	3.57	0.75	-5.8
Net Property, Plant and Equip., 1 Yr. Growth %	43.67	34.17	24.05	2.15	-32.69
Total Assets, 1 Yr. Growth %	52.85	0.99	-0.21	-15.09	-10.38
Tangible Book Value, 1 Yr. Growth %	187.37	-18.43	-6.72	-22.39	-20.75
Common Equity, 1 Yr. Growth %	90.17	-13.83	-5.67	-14.95	-14.57
Cash From Operations, 1 Yr. Growth %	173.33	66.16	-82.3	-50	-150.38
Capital Expenditures, 1 Yr. Growth %	20.06	52.47	17.63	-44.93	-38.25
Levered Free Cash Flow, 1 Yr. Growth %	-126.24	-3.19K	-52.99	23.08	-29.34
Unlevered Free Cash Flow, 1 Yr. Growth %	-180.35	-1.43K	-55.46	25.83	-29.34
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	17.66	22.48	12.44	2.98	0.44
Gross Profit, 2 Yr. CAGR %	6.79	17.66	7.48	-18.76	-19.22
EBITDA, 2 Yr. CAGR %	-9.41	-5.66	-10.17	-92.09	-61.46
EBITA, 2 Yr. CAGR %	-24.58	-35.05	-62.08	87.05	50.51
EBIT, 2 Yr. CAGR %	-27.57	-37.39	-84.01	94.55	39.09
Earnings From Cont. Operations, 2 Yr. CAGR %	140.33	428.96	-37.6	5.65	11.07
Net Income, 2 Yr. CAGR %	137.66	428.96	-37.6	5.65	11.07
Normalized Net Income, 2 Yr. CAGR %	-42.09	-34.41	-1.16	162.87	19.87
Diluted EPS Before Extra, 2 Yr. CAGR %	127.6	398.56	-39.48	5.66	10.86
Accounts Receivable, 2 Yr. CAGR %	27	41.88	-10.29	-10.42	15.38
Inventory, 2 Yr. CAGR %	54.91	48.17	9.44	2.15	-2.58
Net Property, Plant and Equip., 2 Yr. CAGR %	42.69	38.84	29.01	12.57	-17.08
Total Assets, 2 Yr. CAGR %	37.58	24.24	0.39	-7.95	-12.77
Tangible Book Value, 2 Yr. CAGR %	225.38	53.11	-12.77	-14.92	-21.57
Common Equity, 2 Yr. CAGR %	69.94	28.01	-9.84	-10.43	-14.76
Cash From Operations, 2 Yr. CAGR %	70.16	113.11	-45.4	-70.25	-49.81
Capital Expenditures, 2 Yr. CAGR %	94.87	35.3	33.92	-19.52	-41.69
Levered Free Cash Flow, 2 Yr. CAGR %	-61.18	190.69	278.73	-21.74	-18.89
Unlevered Free Cash Flow, 2 Yr. CAGR %	-46.32	237.18	142.19	-25.14	-18.89
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	18.08	18.95	15.98	8.85	1.61
Gross Profit, 3 Yr. CAGR %	10.6	9.41	11.66	-8.82	-13.1
EBITDA, 3 Yr. CAGR %	-1.7	-9.09	-7.77	-80.61	-56.2
EBITA, 3 Yr. CAGR %	-13.09	-31.7	-52.33	13.76	43.47
EBIT, 3 Yr. CAGR %	-15.16	-35.22	-73.16	26.24	46.85
Earnings From Cont. Operations, 3 Yr. CAGR %	36.87	67.6	137.32	-3.1	-16.16
Net Income, 3 Yr. CAGR %	36.8	66.35	137.32	-3.1	-16.16
Normalized Net Income, 3 Yr. CAGR %	-26.48	-44.6	-6.07	57.57	93.68
Diluted EPS Before Extra, 3 Yr. CAGR %	32.24	58.43	128.03	-5.01	-16.3
Accounts Receivable, 3 Yr. CAGR %	36.01	28.63	7.08	1.92	-6.71
Inventory, 3 Yr. CAGR %	65.79	40.52	31.5	6.46	-0.57
Net Property, Plant and Equip., 3 Yr. CAGR %	75.72	39.79	33.72	19.35	-5.16
Total Assets, 3 Yr. CAGR %	42.53	24.1	15.49	-5.06	-8.77
Tangible Book Value, 3 Yr. CAGR %	139.78	105.17	29.79	-16.1	-16.91
Common Equity, 3 Yr. CAGR %	48.11	35.52	15.63	-11.57	-11.83
Cash From Operations, 3 Yr. CAGR %	-7.86	68.82	-6.6	-46.98	-64.54
Capital Expenditures, 3 Yr. CAGR %	62.21	79.57	29.13	-0.42	-26.32
Levered Free Cash Flow, 3 Yr. CAGR %	-63.07	66.97	57.72	160.38	-26.57
Unlevered Free Cash Flow, 3 Yr. CAGR %	-52.31	56.67	70.96	94.7	-26.57
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	30.31	23.29	15.79	12.29	9.49
Gross Profit, 5 Yr. CAGR %	20.95	16.3	9.34	-2.87	-1.9
EBITDA, 5 Yr. CAGR %	20.48	7.82	-5.18	-64.08	-37.53
EBITA, 5 Yr. CAGR %	14.35	-8.26	-37.63	-3.49	-1.31
EBIT, 5 Yr. CAGR %	10.02	-11.09	-56.48	1.09	4.95
Earnings From Cont. Operations, 5 Yr. CAGR %	51.68	49.89	-0.03	39.35	75.16
Net Income, 5 Yr. CAGR %	50.91	49.56	-0.06	38.73	75.16
Normalized Net Income, 5 Yr. CAGR %	-3.03	-14.74	-17.24	5.58	28.4
Diluted EPS Before Extra, 5 Yr. CAGR %	45.3	44.1	-3.27	34.73	70.89
Accounts Receivable, 5 Yr. CAGR %	40.21	28.96	15.15	11.3	10.32
Inventory, 5 Yr. CAGR %	43.06	39.89	40.41	23.69	16.63
Net Property, Plant and Equip., 5 Yr. CAGR %	62.46	54.1	55.29	28.19	10.46
Total Assets, 5 Yr. CAGR %	44.56	27.63	23.89	10.12	3.23
Tangible Book Value, 5 Yr. CAGR %	63.27	102.97	60.01	44.28	6.1
Common Equity, 5 Yr. CAGR %	45.26	29.11	21.44	14.83	2.35
Cash From Operations, 5 Yr. CAGR %	12.66	79.74	-25.26	-15.47	-27.15
Capital Expenditures, 5 Yr. CAGR %	64.6	60.12	50.24	30.26	-6.04
Levered Free Cash Flow, 5 Yr. CAGR %	-24.77	88.01	-6.29	21.61	25.57
Unlevered Free Cash Flow, 5 Yr. CAGR %	-12.81	81.64	-8.65	16.29	34.75